Cargando…

Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma

BACKGROUND: Preoperative maximum standardized uptake value (SUVmax) of 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and serum carcinoembryonic antigen (CEA) have been reported as prognostic factors for lung adenocarcinoma. However, the significance of combined SUVmax and CEA in earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashinokuchi, Asato, Haratake, Naoki, Takenaka, Tomoyoshi, Matsudo, Kyoto, Nagano, Taichi, Watanabe, Kenji, Kosai, Keisuke, Oku, Yuka, Ono, Yuki, Takamori, Shinkichi, Kohno, Mikihiro, Baba, Shingo, Ishigami, Kousei, Yoshizumi, Tomoharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475234/
https://www.ncbi.nlm.nih.gov/pubmed/35962578
http://dx.doi.org/10.1111/1759-7714.14599
_version_ 1784789868697616384
author Hashinokuchi, Asato
Haratake, Naoki
Takenaka, Tomoyoshi
Matsudo, Kyoto
Nagano, Taichi
Watanabe, Kenji
Kosai, Keisuke
Oku, Yuka
Ono, Yuki
Takamori, Shinkichi
Kohno, Mikihiro
Baba, Shingo
Ishigami, Kousei
Yoshizumi, Tomoharu
author_facet Hashinokuchi, Asato
Haratake, Naoki
Takenaka, Tomoyoshi
Matsudo, Kyoto
Nagano, Taichi
Watanabe, Kenji
Kosai, Keisuke
Oku, Yuka
Ono, Yuki
Takamori, Shinkichi
Kohno, Mikihiro
Baba, Shingo
Ishigami, Kousei
Yoshizumi, Tomoharu
author_sort Hashinokuchi, Asato
collection PubMed
description BACKGROUND: Preoperative maximum standardized uptake value (SUVmax) of 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and serum carcinoembryonic antigen (CEA) have been reported as prognostic factors for lung adenocarcinoma. However, the significance of combined SUVmax and CEA in early‐stage lung adenocarcinoma is not well known. METHODS: We retrospectively evaluated the relationship between the combination of SUVmax and CEA and the prognosis of 410 patients with clinical stage IA lung adenocarcinoma who underwent resection. The cutoff values for SUVmax and CEA were determined by receiver operating characteristic curve analysis, and patients were categorized into high SC (SUVmax and CEA) group (SUVmax ≥2.96 and CEA ≥5.3), moderate SC group (either SUVmax <2.96 and CEA ≥5.3 or SUVmax ≥2.96 and CEA <5.3) and low SC group (SUVmax <2.96 and CEA <5.3). RESULTS: Kaplan–Meier curve analysis showed that patients with clinical stage IA lung adenocarcinoma in the high SC group had significantly shorter overall survival (OS) and recurrence‐free survival (RFS) than the other groups (p = 0.011 and p < 0.0001, respectively). Multivariate analysis showed that high SC was an independent prognostic factor of OS (p = 0.029) and RFS (p < 0.0001). CONCLUSIONS: High values of SUVmax and CEA were associated with poor OS and RFS in patients with stage IA lung adenocarcinoma. Simultaneous evaluation of SUVmax and CEA may be an effective prognostic marker to determine the optimal treatment strategy of early‐stage lung adenocarcinoma.
format Online
Article
Text
id pubmed-9475234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-94752342022-09-28 Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma Hashinokuchi, Asato Haratake, Naoki Takenaka, Tomoyoshi Matsudo, Kyoto Nagano, Taichi Watanabe, Kenji Kosai, Keisuke Oku, Yuka Ono, Yuki Takamori, Shinkichi Kohno, Mikihiro Baba, Shingo Ishigami, Kousei Yoshizumi, Tomoharu Thorac Cancer Original Articles BACKGROUND: Preoperative maximum standardized uptake value (SUVmax) of 2‐[18F]‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography and serum carcinoembryonic antigen (CEA) have been reported as prognostic factors for lung adenocarcinoma. However, the significance of combined SUVmax and CEA in early‐stage lung adenocarcinoma is not well known. METHODS: We retrospectively evaluated the relationship between the combination of SUVmax and CEA and the prognosis of 410 patients with clinical stage IA lung adenocarcinoma who underwent resection. The cutoff values for SUVmax and CEA were determined by receiver operating characteristic curve analysis, and patients were categorized into high SC (SUVmax and CEA) group (SUVmax ≥2.96 and CEA ≥5.3), moderate SC group (either SUVmax <2.96 and CEA ≥5.3 or SUVmax ≥2.96 and CEA <5.3) and low SC group (SUVmax <2.96 and CEA <5.3). RESULTS: Kaplan–Meier curve analysis showed that patients with clinical stage IA lung adenocarcinoma in the high SC group had significantly shorter overall survival (OS) and recurrence‐free survival (RFS) than the other groups (p = 0.011 and p < 0.0001, respectively). Multivariate analysis showed that high SC was an independent prognostic factor of OS (p = 0.029) and RFS (p < 0.0001). CONCLUSIONS: High values of SUVmax and CEA were associated with poor OS and RFS in patients with stage IA lung adenocarcinoma. Simultaneous evaluation of SUVmax and CEA may be an effective prognostic marker to determine the optimal treatment strategy of early‐stage lung adenocarcinoma. John Wiley & Sons Australia, Ltd 2022-08-12 2022-09 /pmc/articles/PMC9475234/ /pubmed/35962578 http://dx.doi.org/10.1111/1759-7714.14599 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Hashinokuchi, Asato
Haratake, Naoki
Takenaka, Tomoyoshi
Matsudo, Kyoto
Nagano, Taichi
Watanabe, Kenji
Kosai, Keisuke
Oku, Yuka
Ono, Yuki
Takamori, Shinkichi
Kohno, Mikihiro
Baba, Shingo
Ishigami, Kousei
Yoshizumi, Tomoharu
Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
title Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
title_full Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
title_fullStr Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
title_full_unstemmed Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
title_short Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
title_sort clinical significance of the combination of preoperative suvmax and cea in patients with clinical stage ia lung adenocarcinoma
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475234/
https://www.ncbi.nlm.nih.gov/pubmed/35962578
http://dx.doi.org/10.1111/1759-7714.14599
work_keys_str_mv AT hashinokuchiasato clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT haratakenaoki clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT takenakatomoyoshi clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT matsudokyoto clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT naganotaichi clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT watanabekenji clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT kosaikeisuke clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT okuyuka clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT onoyuki clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT takamorishinkichi clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT kohnomikihiro clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT babashingo clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT ishigamikousei clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma
AT yoshizumitomoharu clinicalsignificanceofthecombinationofpreoperativesuvmaxandceainpatientswithclinicalstageialungadenocarcinoma